SCHEMBL1899227

SCHEMBL1899227

CSC(C)(SC)C(=O)Oc1ccc(C(F)(F)F)cc1NC(=O)C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
KDM4E B2RXH2 6/20 0.43
MAPT P10636 4/20 0.43
HTT P42858 2/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 4/20 0.41
ALDH1A1 P00352 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
ATM Q13315 1/20 0.41
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALOX12 P18054 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634759 0.82 MAPT (0.56) CYP2C19CYP1A2CYP2C9KDM4EMAPT
SCHEMBL1898874 0.74 CETP (0.64) CYP2C19CYP1A2CYP2C9KDM4EHTT
SCHEMBL19669082 0.73 MEN1 (0.57) HTTKMT2AALDH1A1NPSR1MEN1
SCHEMBL30006263 0.73 MEN1 (0.57) HTTKMT2AALDH1A1NPSR1MEN1
SCHEMBL8946084 0.71 GAA (0.48) CYP1A2CYP2C9KDM4EMAPTHTT
SCHEMBL26626261 0.71 CYP1A2 (0.52) CYP2C19CYP1A2CYP2C9KDM4EMAPT
SCHEMBL529149 0.70 CETP (0.65) CYP2C19CYP1A2CYP2C9MAPTKMT2A
SCHEMBL13015660 0.70 KIF11 (0.52) CYP1A2CYP2C9KDM4EKMT2AALDH1A1
SCHEMBL31440788 0.70 KMT2A (0.61) CYP2C19CYP1A2CYP2C9KDM4EMAPT
SCHEMBL31372456 0.70 ELANE (0.43) CYP2C19CYP1A2CYP2C9KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2316447-A1 Method of inhibiting remnant lipoprotein production Japan Tobacco, Inc. (JP) 2011-05-04 EP claimed
EP-1670446-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2006-06-21 EP claimed
WO-2005030185-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2005-04-07 WO claimed
EP-2319509-A1 Method of Inhibiting remnant lipoprotein production Japan Tobacco, Inc. (JP) 2011-05-11 EP disclosed
EP-2316447-A1 Method of inhibiting remnant lipoprotein production Japan Tobacco, Inc. (JP) 2011-05-04 EP disclosed
EP-1670446-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2006-06-21 EP disclosed
WO-2005030185-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2005-04-07 WO disclosed